A Phase I Study of Indoximod [1-methyl-D-tryptophan (D-1MT)] in Patients With Relapsed or Refractory Solid Tumors
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Indoximod (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Biomarker; Pharmacokinetics
- Acronyms D-1MT
- 28 Jun 2012 Status changed from active, no longer recruiting to discontinued, due to lack of enrolment, according to ClinicalTrials.gov record NCT00730609.
- 28 Jun 2012 Status changed from active, no longer recruiting to discontinued, due to lack of enrolment, according to ClinicalTrials.gov record NCT00730609.
- 06 Jun 2009 Additional lesd trial investigator (Jeffrey S) added as reported by Vanderbilt-Ingram Cancer Center.